{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Solriamfetol&page=2", "query": { "intervention": "Solriamfetol", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Solriamfetol&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-01T19:43:55.593Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02348606", "title": "\"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA\"", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Obstructive Sleep Apnea" ], "interventions": [ { "name": "JZP-110", "type": "DRUG" }, { "name": "Placebo oral tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 476, "start_date": "2015-05", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2019-07-23", "last_synced_at": "2026-09-01T19:43:55.593Z", "location_count": 45, "location_summary": "Glendale, Arizona • Scottsdale, Arizona • Little Rock, Arkansas + 38 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02348606" }, { "nct_id": "NCT07773883", "title": "An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "ADHD" ], "interventions": [ { "name": "Solriamfetol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Axsome Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "6 Years to 18 Years" }, "enrollment_count": 300, "start_date": "2026-08-06", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-08-19", "last_synced_at": "2026-09-01T19:43:55.593Z", "location_count": 2, "location_summary": "Dothan, Alabama • Maitland, Florida", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Maitland", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07773883" }, { "nct_id": "NCT06413420", "title": "SUNOSI® (Solriamfetol) Pregnancy Registry", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Narcolepsy", "Obstructive Sleep Apnea", "Pregnant Women and Their Offspring" ], "interventions": [ { "name": "Sunosi (solriamfetol)", "type": "DRUG" }, { "name": "Other prescription wake-promoting medications or stimulants", "type": "DRUG" }, { "name": "No treatment", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Axsome Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 1731, "start_date": "2019-07-31", "completion_date": "2029-09", "has_results": false, "last_update_posted_date": "2024-05-14", "last_synced_at": "2026-09-01T19:43:55.593Z", "location_count": 2, "location_summary": "Morrisville, North Carolina • Wilmington, North Carolina", "locations": [ { "city": "Morrisville", "state": "North Carolina" }, { "city": "Wilmington", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06413420" }, { "nct_id": "NCT04788953", "title": "Clinical Trial of Solriamfetol for Excessive Sleepiness Related to Shift Work Disorder", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Excessive Sleepiness", "Shift-work Disorder" ], "interventions": [ { "name": "Solriamfetol Oral Tablet", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Charles A. Czeisler, PhD, MD", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 84, "start_date": "2021-07-21", "completion_date": "2024-04-19", "has_results": true, "last_update_posted_date": "2025-09-24", "last_synced_at": "2026-09-01T19:43:55.593Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04788953" }, { "nct_id": "NCT06360419", "title": "Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "Solriamfetol 300 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Axsome Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 346, "start_date": "2024-03-18", "completion_date": "2025-03-26", "has_results": false, "last_update_posted_date": "2026-01-05", "last_synced_at": "2026-09-01T19:43:55.593Z", "location_count": 40, "location_summary": "Little Rock, Arkansas • Bellflower, California • Encino, California + 35 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Bellflower", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Lemon Grove", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06360419" }, { "nct_id": "NCT06404099", "title": "RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Long COVID", "Long COVID-19", "Hypersomnia" ], "interventions": [ { "name": "Modafinil", "type": "DRUG" }, { "name": "Modafinil Placebo", "type": "DRUG" }, { "name": "Solriamfetol", "type": "DRUG" }, { "name": "Solriamfetol Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 361, "start_date": "2024-08-12", "completion_date": "2026-04-20", "has_results": false, "last_update_posted_date": "2026-06-03", "last_synced_at": "2026-09-01T19:43:55.593Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06404099" }, { "nct_id": "NCT06413433", "title": "Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Binge-Eating Disorder" ], "interventions": [ { "name": "Solriamfetol 150 mg", "type": "DRUG" }, { "name": "Solriamfetol 300 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Axsome Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 450, "start_date": "2024-04-26", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-07-28", "last_synced_at": "2026-09-01T19:43:55.593Z", "location_count": 44, "location_summary": "Encino, California • Garden Grove, California • Long Beach, California + 38 more", "locations": [ { "city": "Encino", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06413433" }, { "nct_id": "NCT02348619", "title": "\"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA\"", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Obstructive Sleep Apnea" ], "interventions": [ { "name": "JZP-110", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 174, "start_date": "2015-05", "completion_date": "2016-11", "has_results": true, "last_update_posted_date": "2019-09-09", "last_synced_at": "2026-09-01T19:43:55.593Z", "location_count": 22, "location_summary": "Birmingham, Alabama • Oceanside, California • Orange, California + 18 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Oceanside", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Lakewood", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02348619" }, { "nct_id": "NCT04789174", "title": "Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Excessive Daytime Sleepiness", "Obstructive Sleep Apnea", "Impaired Cognitive Function" ], "interventions": [ { "name": "Solriamfetol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Axsome Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 59, "start_date": "2021-05-17", "completion_date": "2022-09-19", "has_results": true, "last_update_posted_date": "2026-01-26", "last_synced_at": "2026-09-01T19:43:55.593Z", "location_count": 15, "location_summary": "Los Angeles, California • Santa Ana, California • Jacksonville, Florida + 11 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Gainesville", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04789174" }, { "nct_id": "NCT06878976", "title": "A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating Disorder", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Binge-Eating Disorder" ], "interventions": [ { "name": "Solriamfetol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Axsome Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "56 Years", "sex": "ALL", "summary": "18 Years to 56 Years" }, "enrollment_count": 236, "start_date": "2025-02-20", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-08-11", "last_synced_at": "2026-09-01T19:43:55.593Z", "location_count": 33, "location_summary": "Encino, California • Long Beach, California • Santa Ana, California + 28 more", "locations": [ { "city": "Encino", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "West Covina", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06878976" } ] }